Could the New Stratus Imaging PACS Viewer Help Streamline Radiology Workflows?
Offering a variety of features to enhance efficiency, bolster security and reduce IT overhead, the cloud-native SaaS platform may help radiologists minimize workflow issues that can impede practices with high imaging volume.
In the ongoing effort to help optimize radiology workflows, Change Healthcare has launched the Stratus Imaging PACS viewer.
One of the benefits of the Stratus Imaging PACS viewer is the StoryView™ presentation, which enables radiologists to see imaging histories and summarized exam narratives. Change Healthcare said the StoryView presentation allows one to track the progression of a disease or condition and facilitates improved decision-making on the course of treatment.
Unified worklists and the ability to access quality clinical images from mobile devices as well as desktop computers enable ease of image reading access for radiologists, according to Change Healthcare.
For high-volume radiology practices, Change Healthcare said the Stratus Imaging PACS viewer facilitates smooth adoption and minimal IT labor with a cloud-native, software as a service (SaaS) platform. The company added that functionality and security updates are done automatically without any downtime.
In regard to security, Change Healthcare maintained the Stratus Imaging PACS viewer is HITRUST-certified* and SOC 2 Type 2 compliant.
The Stratus Imaging PACS viewer is available through a price-per-study SaaS model, according to Change Healthcare.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
